1. X
  2. NatureRevClinOncol
Log inSign up
NatureRevClinOncol
14.5K posts
Image
user avatar
NatureRevClinOncol
@NatRevClinOncol
The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal.
London, UK
nature.com/nrclinonc/inde…
Joined August 2011
240
Following
42.2K
Followers
RepliesRepliesMediaMedia

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
  • user avatar
    NatureRevClinOncol
    @NatRevClinOncol
    Oct 11, 2022
    In a Review now online, @NicoleKuderer, @ADesaiMD, @maryam_lustberg and @gary_lyman explain the most common acute toxicities in patients with cancer receiving chemotherapy and discuss management options: nature.com/articles/s4157…
    Image
    Image
    Image
    Image
  • user avatar
    NatureRevClinOncol
    @NatRevClinOncol
    Dec 25, 2022
    The #7 most visited long article published in @natrevclinoncol in 2022 is: nature.com/articles/s4157…
    101K0101K
  • user avatar
    NatureRevClinOncol
    @NatRevClinOncol
    Dec 27, 2022
    The fifth most visited long article published in @natrevclinoncol in 2022 is:
    Content cover image
    B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical...
    From nature.com
    62K062K
  • user avatar
    NatureRevClinOncol
    @NatRevClinOncol
    Mar 30, 2022
    In a Review now published online, Mikael Pittet, Olivier Michielin & Denis Migliorini discuss the clinical relevance of macrophages in cancer, both as biomarkers and in therapeutic approaches nature.com/articles/s4157…
    Image
    Image
    Image
    Image
  • user avatar
    NatureRevClinOncol
    @NatRevClinOncol
    Dec 24, 2022
    The #8 most visited long article published in @natrevclinoncol in 2022 is:
    nature.com
    Senescence and cancer — role and therapeutic opportunities
    Nature Reviews Clinical Oncology - The entry of cells into senescence can act as a barrier to tumorigenesis; however, in certain contexts senescent malignant and non-malignant cells can acquire...
    38K038K
  • user avatar
    NatureRevClinOncol
    @NatRevClinOncol
    Dec 30, 2022
    The second most visited long article published in @NatRevClinOncol in 2022 is:
    Content cover image
    Clinical implications of T cell exhaustion for cancer immunotherapy
    From nature.com
    38K038K
  • user avatar
    NatureRevClinOncol
    @NatRevClinOncol
    Oct 11, 2022
    In a new Review @AndrewChowMDPhD @KarloPerica @KlebanoffLab & @wolchokj discuss the immunobiology and clinical implications of T cell exhaustion for cancer immunotherapy: nature.com/articles/s4157… @MSKCancerCenter @WeillCornell
    Image
    Image
    Image
    Image
  • user avatar
    NatureRevClinOncol
    @NatRevClinOncol
    Apr 1, 2022
    In a new Review online in time for weekend reading, Wolf Fridman and colleagues discuss 'B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome': nature.com/articles/s4157… #ImmunoOnc #camicroenv
    Image
    Image
    Image
    Image
  • user avatar
    NatureRevClinOncol
    @NatRevClinOncol
    Jul 13, 2022
    In a Review now published online, @RohanKatipally @SeanPitroda @ajuloorimd @Docace911 and @rweichselbaum provide the current knowledge on oligometastatic cancer #metastasis nature.com/articles/s4157…
    Image
  • user avatar
    NatureRevClinOncol
    @NatRevClinOncol
    Jul 12, 2021
    In a Review now online, Patricia Steeg discusses the role of the blood–tumour barrier in cancer biology and therapy nature.com/articles/s4157…
    Image
    Image
    Image
    Image
  • user avatar
    NatureRevClinOncol
    @NatRevClinOncol
    Jan 26, 2022
    New Review by Douglas Johnson, Caroline Nebhan, Javid Moslehi (@CardioOncology) & Justin Balko now live online: 'Immune-checkpoint inhibitors: long-term implications of toxicity' nature.com/articles/s4157… #ImmunoOnc #medonc
    Image
    Image
    Image
    Image
  • user avatar
    NatureRevClinOncol
    @NatRevClinOncol
    Feb 7, 2024
    This new Review describes the roles of dendritic cells (DCs) as orchestrators of anticancer immunity, focusing on novel insights on DC heterogeneity gleaned from single-cell studies & how this knowledge might be leveraged to improve immunotherapy: nature.com/articles/s4157…
    Image
    Image
    Image
    Image
    34K034K
  • user avatar
    NatureRevClinOncol
    @NatRevClinOncol
    Nov 22, 2022
    In the phase III externally controlled trial of autologous tumour lysate-loaded DC vaccination (DCVax-L) vs SoC for newly diagnosed or recurrent glioblastoma demonstrates promising median OS durations & meaningful increases in the tails of the OS curves:
    Image
    Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma
    From jamanetwork.com
  • user avatar
    NatureRevClinOncol
    @NatRevClinOncol
    Oct 12, 2023
    In a new Perspective, Walia, Tuia & @VPrasadMDMPH discuss the adoption of composite end points in oncology, their pro and cons, and advocate for separate reporting of component events to enable a better understanding of cancer biology and trial results: nature.com/articles/s4157…
    Image
    Image
    Image
    Image
    230K0230K
Advertisement
Advertisement